This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Guideline

. 2003 Jan;120(2):187-200.

doi: 10.1046/j.1365-2141.2003.03907.x.

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

David Bowen¹, Dominic Culligan, Simon Jowitt, Stephen Kelsey, Ghulam Mufti, David Oscier, Jane Parker; UK MDS Guidelines Group

Affiliations

PMID: 12542475
DOI: 10.1046/j.1365-2141.2003.03907.x

Guideline

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

David Bowen et al. Br J Haematol. 2003 Jan.

. 2003 Jan;120(2):187-200.

doi: 10.1046/j.1365-2141.2003.03907.x.

Authors

David Bowen¹, Dominic Culligan, Simon Jowitt, Stephen Kelsey, Ghulam Mufti, David Oscier, Jane Parker; UK MDS Guidelines Group

Affiliation

¹ Molecular and Cellular Pathology, Ninewells Hospital, Dundee, UK.

PMID: 12542475
DOI: 10.1046/j.1365-2141.2003.03907.x

No abstract available

PubMed Disclaimer

Similar articles

[Myeloproliferative syndromes].
Ganser A. Ganser A. Ther Umsch. 1996 Feb;53(2):97-102. Ther Umsch. 1996. PMID: 8629270 Review. German.
Therapeutic spectrum in the treatment of myelodysplastic syndromes.
Hofmann WK, Baldus C, Uharek L, Thiel E. Hofmann WK, et al. Expert Opin Pharmacother. 2004 Dec;5(12):2451-8. doi: 10.1517/14656566.5.12.2451. Expert Opin Pharmacother. 2004. PMID: 15571463
[Treatment of MDS].
Usuki K. Usuki K. Rinsho Ketsueki. 2014 Oct;55(10):1882-92. Rinsho Ketsueki. 2014. PMID: 25297752 Review. Japanese. No abstract available.
Granulocyte colony-stimulating factor and erythropoietin for the anemia of myelodysplastic syndromes: a real improvement with respect to erythropoietin alone?
Musto P, Falcone A, Carotenuto M, Catalano L, Cennamo A, Rotoli B. Musto P, et al. Blood. 1994 Sep 1;84(5):1687-8. Blood. 1994. PMID: 7520783 No abstract available.
Risk-based management of myelodysplastic syndrome.
Steensma DP, Tefferi A. Steensma DP, et al. Oncology (Williston Park). 2007 Jan;21(1):43-54; discussion 57-8, 62. Oncology (Williston Park). 2007. PMID: 17313156 Review.

See all similar articles

Cited by

Myelodysplastic syndrome: An update on diagnosis and therapy.
Koppel A, Schiller G. Koppel A, et al. Curr Hematol Malig Rep. 2009 Jan;4(1):10-6. doi: 10.1007/s11899-009-0002-9. Curr Hematol Malig Rep. 2009. PMID: 20425433
A prospective study of cyclosporine A treatment of patients with low-risk myelodysplastic syndrome: presence of CD55(-)CD59(-) blood cells predicts platelet response.
Ishikawa T, Tohyama K, Nakao S, Yoshida Y, Teramura M, Motoji T, Takatoku M, Kurokawa M, Mitani K, Uchiyama T, Omine M. Ishikawa T, et al. Int J Hematol. 2007 Aug;86(2):150-7. doi: 10.1532/IJH97.07052. Int J Hematol. 2007. PMID: 17875530 Clinical Trial.
Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform.
Valent P, Krieger O, Stauder R, Wimazal F, Nösslinger T, Sperr WR, Sill H, Bettelheim P, Pfeilstöcker M. Valent P, et al. Eur J Clin Invest. 2008 Mar;38(3):143-9. doi: 10.1111/j.1365-2362.2007.01915.x. Epub 2008 Jan 24. Eur J Clin Invest. 2008. PMID: 18218040 Free PMC article.
Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome.
Mailloux AW, Sugimori C, Komrokji RS, Yang L, Maciejewski JP, Sekeres MA, Paquette R, Loughran TP Jr, List AF, Epling-Burnette PK. Mailloux AW, et al. J Immunol. 2012 Sep 15;189(6):3198-208. doi: 10.4049/jimmunol.1200602. Epub 2012 Aug 8. J Immunol. 2012. PMID: 22875800 Free PMC article.
Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).
Valent P, Wimazal F, Schwarzinger I, Sperr WR, Geissler K. Valent P, et al. Wien Klin Wochenschr. 2003 Aug 14;115(13-14):515-36. doi: 10.1007/BF03041035. Wien Klin Wochenschr. 2003. PMID: 13677270 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information